OPUS Biotech Press Release Archives - Opus Biotech Communications

Opus Biotech Communications , Vanguard Leadership Group Form Strategic Alliance

On June 11, 2019 / OPUS Biotech Press Release

Opus Biotech Communications, Vanguard Leadership Group Form Strategic Alliance SEATTLE, June 11, 2019 — Opus Biotech Communications is partnering with The Vanguard Leadership Group, of New York, to offer CEOs in emerging biotech, pharmaceutical and medical device companies a unique management program and services to help them achieve their business and professional development goals. The Vanguard Group for Leadership supports senior executives as they build high-performance organizations and take their leadership, and their teams, to higher levels. Vanguard founder Ken Banta has been a principal leader of eight mergers and turnarounds, including the text-book transformations of Pharmacia Corporation and Schering-Plough. Opus Biotech founders, Dan Eramian and Charles Craig, have been part of the biotech industry for the past 25 years working with CEOs in structuring PR, IR, public policy and crisis communications campaigns, as well as constructing ethical frameworks to guide executive decision making. “Our alliance with Ken and his team

Opus Biotech Communications Will be Guest Panelists for Women In Bio Webinar on Company Reputation and Investor Relations

On November 8, 2018 / OPUS Biotech Press Release

Opus Biotech Communications Will be Guest Panelists for Women In Bio Webinar on Company Reputation and Investor Relations Seattle, WA, November 1, 2018 — Opus Biotech Communications, a life sciences public affairs and investor relations consultancy based in Seattle with branches in Atlanta, Newport Beach and San Francisco, today announced it will be guest panelists on Women In Bio National Webinar, November 14 at 2:00 pm Eastern. Discussion will center on building company reputations, along with public and investors relations specifically for biotech and life sciences companies. Opus principals Penny Jo Welsch and Dan Eramian will lead the discussion, followed by a Q & A. “Women In Bio is a fast-growing organization which actively supports career growth for women in the life sciences,” said Ms. Welsch. “We are very excited to support the goals of this organization and look forward to sharing our communication expertise with life science entrepreneurs.” Webinar

Opus Biotech Communications Joins Biocom and Women in BIO

On April 24, 2018 / OPUS Biotech Press Release

Opus Biotech Communications Joins Biocom and Women in BIO Seattle, WA , April 24, 2018 — Opus Biotech Communications, a life sciences public affairs and investor relations consultancy based in Seattle with branches in Atlanta, Newport Beach and San Francisco, today announced it has joined Biocom, a leading life sciences trade and advocacy group in California. “Biocom represents over 1,000 research institutions and life science companies and provides one of the strongest voices in the nation for the life science industry,” Opus Principal and former first VP of Communications for the Biotechnology Industry Organization Dan Eramian stated. “We are proud to join this growing organization and look forward to contributing.” “Industry groups like Biocom are vital to the success of startups, which are the leaders of innovation in medical research,” said Opus Principal Charles Craig, a former president of Georgia Bio and experienced biotech journalist. “Biocom has become a key

Opus Biotech Communications Adds New Clients
Web and social media expert, PJWCreative joins Opus as affiliate partner.

On September 25, 2017 / OPUS Biotech Press Release

Opus Biotech Communications Adds New Clients Web and social media expert, PJWCreative joins Opus as affiliate partner. Seattle, WA , September 25, 2017– Opus Biotech Communications, a life sciences public affairs and investor relations consultancy based in Seattle, Atlanta and San Francisco, today announced the addition of two new clients: Cyrus Biotechnology and Lumen Bioscience, both based in Seattle. Opus Biotech also said PJW Creative, a web and social media firm, based in Orange County, CA has joined the company as an affiliate partner. Cyrus Biotechnology has developed novel computational software which allows for the designing and modeling of new proteins and drugs on a computer. Lumen Bioscience has produced a new algae-based platform which can be used for industrial and drug products. Opus Biotech’s other past and present clients include WuXi AppTec, bioNorthTX, Saranas, Cancer Prevention Pharmaceuticals, NanOlogy, BioVentures for Global Health, Kineta, KPI Therapeutics, GeoVax, Georgia Dental Hygienists’

Opus Biotech Communications Expands Operations to San Francisco
Forms New Affiliation with PJ Johnston Communications

On March 7, 2017 / OPUS Biotech Press Release

SAN FRANCISCO, March 7, 2017– Opus Biotech Communications, a life sciences public and investor relations consultancy based in Seattle and Atlanta, today announced the opening of a San Francisco office through an affiliation with PJ Johnston Communications, a long established San Francisco based public relations firm. Opus was founded by Dan Eramian, former first Vice President of Communications for the Biotechnology Industry Organization (BIO), and Charles Craig, a writer and editor for leading biotech publications and mainstream media organizations, and former President of Georgia Bio. “Having a presence in San Francisco allows us to better serve clients especially our target audience, emerging biotech companies, which need to raise their profile and tell their story to investors but may have limited resources,” said Eramian. “Opus is pleased to be associated with PJ Johnston Communications,” Craig said. “Mr. Johnston has been a major figure in the San Francisco public relations community and

Opus Biotech Communications Named Preferred PR/IR Partner for bionorthTX members

On December 8, 2016 / OPUS Biotech Press Release

Opus Biotech Communications Named Preferred PR/IR Partner for bionorthTX members DALLAS & FORTH WORTH, Texas—bionorthTX President and CEO, Harold Strong announced that Opus Biotech Communications (www.opusbiotech.com) will be the organization’s preferred PR/IR provider. Under this new partnership bionorthTX members are now eligible to receive discounted rates for all the communications and investor relations services the firm offers to emerging and established life sciences companies. “This program compliments other discount programs offered by bionorthTX as a member benefit,” Strong added. “Start-up companies are focused on advancing their research,” said Opus Biotech cofounder Dan Eramian, “but unless they can compellingly articulate the value of their unique stories to investors early on, they risk leaving their technology in the lab.” “Emerging life sciences companies live in a highly competitive environment,” added Opus cofounder Charles Craig. “They must prove now not only that their science works, but also convince a price sensitive health care

Veteran Biotech Communications Execs Launch Opus Biotech Communications, New PR/IR Services for Emerging Biotech and Life Sciences Companies

On October 12, 2016 / OPUS Biotech Press Release

Veteran Biotech Communications Execs Launch Opus Biotech Communications, New PR/IR Services for Emerging Biotech and Life Sciences Companies SEATTLE–October 12, 2016 –Two experienced executives, a former Biotechnology Industry Organization Vice President of Communications and a former President of Georgia Bio, announced the formation of Opus Biotech Communications (www.opusbiotech.com) with offices in Seattle and Atlanta. Opus Biotech will offer reputation management, strategic public relations and investor relations services geared toward early-stage companies as well as communication audits and programs for established companies. “Start-up companies are focused on advancing their research,” said Opus Biotech cofounder Dan Eramian, “but unless they can compellingly articulate the value of their unique stories to investors early on, they risk leaving their technology in the lab.” Eramian and cofounder Charles Craig have a combined four decades experience in public relations, investor relations, government affairs and reputation building. “Start-up companies live in a highly competitive environment,” said Craig.

Archive for the OPUS Biotech Press Release Category